Altimmune (ALT) Non-Current Deferred Tax Liability (2017 - 2019)

Altimmune (ALT) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $58500.0 in Q2 2019.

• On a quarterly basis, Non-Current Deferred Tax Liability fell 98.68% year-over-year to $58500.0 in Q2 2019; TTM through Jun 2019 was $58500.0, a 98.68% decrease from a year earlier, with the FY2018 full-year figure at $58500.0, down 99.01% from the prior year.
• Non-Current Deferred Tax Liability for Q2 2019 stood at $58500.0, roughly flat from $58500.0 in the prior quarter.
• Over the last five years, Non-Current Deferred Tax Liability for ALT reached as high as $8.5 million in Q2 2017 and fell as low as $58500.0 in Q4 2018.
• Historically, Non-Current Deferred Tax Liability has averaged $4.0 million across 3 years, with a median of $4.4 million in 2018.
• On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 48.14% in 2018 and fell as far as 99.01% in 2018.
• Year by year, Non-Current Deferred Tax Liability stood at $5.9 million in 2017, then plunged by 99.01% to $58500.0 in 2018, then changed by 0.0% to $58500.0 in 2019.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $58500.0 in Q2 2019, $58500.0 in Q1 2019, and $58500.0 in Q4 2018.